𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Enhanced expression of Annexin A4 in clear cell carcinoma of the ovary and its association with chemoresistance to carboplatin

✍ Scribed by Ayako Kim; Takayuki Enomoto; Satoshi Serada; Yutaka Ueda; Tsuyoshi Takahashi; Barry Ripley; Takashi Miyatake; Masami Fujita; Chun Man Lee; Koji Morimoto; Minoru Fujimoto; Tadashi Kimura; Tetsuji Naka


Publisher
John Wiley and Sons
Year
2009
Tongue
French
Weight
247 KB
Volume
125
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Clear cell carcinoma (CCC) of the ovary is known to be highly resistant to platinum‐based chemotherapy. The purpose of our study was to identify a candidate protein that is associated with chemoresistance of CCC and to investigate the specific mechanism of chemoresistance conferred by the identified protein. Enhanced expression of Annexin A4 (Anx A4) was identified in ovarian CCC cells using 2‐D differential gel electrophoresis (2D‐DIGE) and mass spectrometry. Anx A4 levels were elevated in CCC cells compared with non‐CCC cells as determined by real‐time RT‐PCR and Western blot analysis. Immunohistochemical analysis of Anx A4 was performed in 126 epithelial ovarian cancer tissue samples and demonstrated significantly elevated levels of Anx A4 protein levels in ovarian CCC tumors compared with ovarian serous and endometrioid tumors (p < 0.01). Anx A4‐transfected ovarian non‐CCC cells were more resistant to carboplatin (IC50 = 42 μM) compared with control cells (IC50 = 23 μM) as determined by modified MTT assay. Intracellular platinum levels were significantly lower in Anx A4‐transfected cells compared with control cells after carboplatin treatment (p = 0.0020) and after an additional 360 min of carboplatin‐free incubation (p = 0.0004), as measured by atomic absorption spectrophotometry. Expression of Anx A4 is elevated in ovarian CCC tumors and is associated with chemoresistance in cultured ovarian cancer cells. These results demonstrate that Anx A4 confers chemoresistance in ovarian cancer cells in part by enhancing drug efflux. Thus, Anx A4 may represent a novel therapeutic target of chemoresistance in patients with ovarian CCC. © 2009 UICC


📜 SIMILAR VOLUMES


Expression of the metastasis-associated
✍ Yasushi Toh; Takefumi Ohga; Kazuya Endo; Eisuke Adachi; Hiroki Kusumoto; Masaru 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 232 KB 👁 1 views

## Abstract Metastasis‐associated protein MTA1 and histone deacetylase form a protein complex with histone deacetylase activity that plays an important role in histone deacetylation, alteration of chromatin structure and transcriptional control. The precise role of the MTA1 protein in the malignant

Association of sporadic chondrocalcinosi
✍ Yun Zhang; Kristen Johnson; R. Graham G. Russell; B. Paul Wordsworth; Andrew J. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 2 views

## Abstract ## Objective Certain mutations in __ANKH__, which encodes a multiple‐pass transmembrane protein that regulates inorganic pyrophosphate (PPi) transport, are linked to autosomal‐dominant familial chondrocalcinosis. This study investigated the potential for __ANKH__ sequence variants to p

Association of p73 G4C14-to-A4T14 polymo
✍ Xuemei Ji; Erich M. Sturgis; Chong Zhao; Carol J. Etzel; Qingyi Wei; Guojun Li 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 1 views

## Abstract ## BACKGROUND: The tumor protein p73 interacts with the human papillomavirus type 16 (HPV‐16) oncoproteins E6 and E7, and __p73__ variation may modify the interaction between p73 protein and HPV‐16 oncogenic proteins and contribute to cellular malignant transformation. ## METHODS: In